001     178445
005     20240229143547.0
024 7 _ |a 10.1182/bloodadvances.2021006061
|2 doi
024 7 _ |a pmid:35016204
|2 pmid
024 7 _ |a 2473-9529
|2 ISSN
024 7 _ |a 2473-9537
|2 ISSN
024 7 _ |a 2476-9537
|2 ISSN
024 7 _ |a altmetric:120695694
|2 altmetric
037 _ _ |a DKFZ-2022-00071
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Stalmann, Ursula S A
|b 0
245 _ _ |a Genetic barcoding systematically comparing genes in del(5q) MDS reveals a central role for CSNK1A1 in clonal expansion.
260 _ _ |a Washington, DC
|c 2022
|b American Society of Hematology
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1648038338_3499
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2022 Mar 22;6(6):1780-1796
520 _ _ |a How genetic haploinsufficiency contributes to the clonal dominance of hematopoietic stem cells (HSC) in del(5q) myelodysplastic syndrome (MDS) remains unresolved. Using a genetic barcoding strategy, a systematic comparison was carried out on genes implicated in the pathogenesis of del(5q) MDS in direct competition with each other and wild-type (WT) cells with single clone resolution. Csnk1a1 haploinsufficient HSCs expanded (oligo)clonally and outcompeted all other tested genes and combinations. Csnk1a1-/+ multipotent progenitors showed a pro-proliferative gene signature and HSCs a downregulation of inflammatory signaling/immune response. In validation experiments, Csnk1a1-/+ HSCs outperformed their WT counterparts under a chronic inflammation stimulus, also known to be caused by neighboring genes on chromosome 5. A crucial role for Csnk1a1 haploinsufficiency in the selective advantage of the 5q- HSC is therefore proposed. It is implemented by creation of a unique competitive advantage through increased HSC self-renewal and proliferation capacity, as well as increased fitness under inflammatory stress.
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Ticconi, Fabio
|0 0000-0001-8905-6657
|b 1
700 1 _ |a Snoeren, Inge A M
|b 2
700 1 _ |a Li, Ronghui
|b 3
700 1 _ |a Gleitz, Helene
|0 0000-0001-6138-8916
|b 4
700 1 _ |a Cowley, Glenn
|b 5
700 1 _ |a McConkey, Marie E
|b 6
700 1 _ |a Wong, Aaron Benson
|0 0000-0003-1650-2710
|b 7
700 1 _ |a Schmitz, Stephani
|b 8
700 1 _ |a Fuchs, Stijn N R
|b 9
700 1 _ |a Sood, Shubhankar
|0 P:(DE-He78)dbe2fd9578ec0bf59e0e17592b04f22f
|b 10
700 1 _ |a Leimkühler, Nils Bastian
|0 0000-0003-2530-4329
|b 11
700 1 _ |a Martinez-Høyer, Sergio
|b 12
700 1 _ |a Banjanin, Bella
|b 13
700 1 _ |a Root, David E
|0 0000-0001-5122-861X
|b 14
700 1 _ |a Brümmendorf, Tim Henrik
|0 0000-0002-9677-3723
|b 15
700 1 _ |a Pearce, Juliette
|b 16
700 1 _ |a Schuppert, Andreas
|b 17
700 1 _ |a Bindels, Eric
|b 18
700 1 _ |a Essers, Marieke
|0 P:(DE-He78)ba3fae49054b6bfaaa289b05ecd936d6
|b 19
|u dkfz
700 1 _ |a Heckl, Dirk
|b 20
700 1 _ |a Stiehl, Thomas Peter
|0 0000-0001-9686-9197
|b 21
700 1 _ |a Costa, Ivan G
|0 0000-0003-2890-8697
|b 22
700 1 _ |a Ebert, Benjamin L
|0 0000-0003-0197-5451
|b 23
700 1 _ |a Schneider, Rebekka K
|b 24
773 _ _ |a 10.1182/bloodadvances.2021006061
|g p. bloodadvances.2021006061
|0 PERI:(DE-600)2876449-3
|n 6
|p 1780-1796
|t Blood advances
|v 6
|y 2022
|x 2473-9529
909 C O |p VDB
|o oai:inrepo02.dkfz.de:178445
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)dbe2fd9578ec0bf59e0e17592b04f22f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)ba3fae49054b6bfaaa289b05ecd936d6
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-31
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-22
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BLOOD ADV : 2021
|d 2022-11-22
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b BLOOD ADV : 2021
|d 2022-11-22
920 1 _ |0 I:(DE-He78)A011-20160331
|k A011
|l A011 Stressinduzierte Aktivierung von hämatopoetischen Stammzellen
|x 0
920 1 _ |0 I:(DE-He78)V960-20160331
|k V960
|l V960 HI-Stem
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A011-20160331
980 _ _ |a I:(DE-He78)V960-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21